You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).
This page has been updated recently.
Public Workshop – Complex Issues in Developing Drug and Biological Products for Rare Diseases
Posted: 10/22/2013
October 21, 2013 Approval Letter - Agriflu
Posted: 10/22/2013
October 18, 2013 Approval Letter -PENTACEL
Posted: 10/22/2013
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
